Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Levetiracetam for Treatment of Pain Associated With Fibromyalgia

This study has been completed.
UCB Pharma
Information provided by:
University of California, San Francisco Identifier:
First received: November 15, 2005
Last updated: May 10, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2005
  Primary Completion Date: March 2005 (Final data collection date for primary outcome measure)